Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

Go back to Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001
(NASDAQ: IOVA) Delayed: 4.06 +0.15 (3.84%)
Previous Close $3.91    52 Week High
Open $3.92    52 Week Low
Day High $4.20    P/E N/A 
Day Low $3.91    EPS
Volume 11,624,194